Typicality: | 0.447 |
Saliency: | 0.385 |
often | 3 | temporal |
between 2002 | 2 | temporal |
trial → be sponsored by → the national cancer institute | 19 |
trial → be funded by → the national cancer institute | 11 |
trial → be funded by → the u.s. national cancer institute | 3 |
negative | neutral | positive |
0.116 | 0.831 | 0.053 |
Raw frequency | 33 |
Normalized frequency | 0.385 |
Modifier score | 0.600 |
Perplexity | 17.901 |